Eiko LifeSciences Limited (BOM:540204)

India · Delayed Price · Currency is INR

45.63

-0.27 (-0.59%)

At close: Sep 11, 2026

Eiko LifeSciences Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	587.44	525.71	376.64	279.29	183.21	254.12
Revenue Growth	56.13%	39.58%	34.86%	52.44%	-27.90%	111.93%
Gross Profit	122.22	111.62	48.59	25.14	22.07	27.96
Operating Income	68.48	62.86	20.23	9.5	3.22	7.53
Net Income	48.9	44.96	21.06	7.52	7.69	7.06
Earnings Per Share	3.27	3.19	1.62	0.73	0.79	0.90
EPS Growth	64.40%	97.49%	121.73%	-7.26%	-12.72%	-44.03%

Revenue by Geography

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	462.72	357.36	279.29	179.76	236.76
Export	-	2.96	-	3.42	17.36
Unallocated	63	16.32	-	0.04	0.21
Total	525.71	376.64	279.29	183.22	254.33

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	136.14	136.14	117.81	133.46	6.12	2.17
Total Debt	47.3	47.3	27.63	-	0.54	46.28
Net Cash (Debt)	88.84	88.84	90.17	133.46	5.59	-44.1
Net Cash Growth	-	-1.48%	-32.44%	2288.33%	-	-
Net Cash Per Share	5.95	6.31	6.92	12.94	0.57	-5.65

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	22.5	27.8	-70.8	42.24	-77.27
Capital Expenditures	-	-	-102.91	-3.47	-2.25	-1.55
Free Cash Flow	-	22.5	-75.11	-74.26	39.99	-78.82
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	20.80%	21.23%	12.90%	9.00%	12.05%	11.00%
Operating Margin	11.66%	11.96%	5.37%	3.40%	1.76%	2.96%
Pretax Margin	12.99%	13.54%	8.14%	3.52%	5.60%	3.71%
Profit Margin	8.32%	8.55%	5.59%	2.69%	4.20%	2.78%
FCF Margin	-	4.28%	-19.94%	-26.59%	21.83%	-31.02%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 12, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	13.94	16.77	31.99	95.35	82.68	57.15
P/FCF Ratio	29.09	33.51	-	-	15.89	-
PS Ratio	1.11	1.43	1.79	2.57	3.47	1.59